Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
More News and Success Stories.
-
26 Mar 2026
See more Why global food leaders choose CataloniaWhy global food leaders choose Catalonia
-
20 Mar 2026
See more UK-based Ark Data Centres to open major Barcelona facility, creating 500 skilled jobs in Catalonia’s tech sectorUK-based Ark Data Centres to open major Barcelona facility, creating 500 skilled jobs in Catalonia’s tech sector
-
18 Feb 2026
See more Mediterra DataCenters to develop a 100% green-powered data center in BarcelonaMediterra DataCenters to develop a 100% green-powered data center in Barcelona
-
16 Feb 2026
See more US company Elian lays foundation stone for Barcelona plant-based protein expansionUS company Elian lays foundation stone for Barcelona plant-based protein expansion
